Durham startup Tellus moves closer to OK for neonatal brain treatment Date Published: October 23, 2020 DURHAM – Tellus Therapeutics is getting closer to approval for its neonatal brain injury treatment. This week, the Durham-based biotech…
Now hear this: Durham’s MED-EL Medical Electronics wins Innovator award Date Published: October 23, 2020 RESEARCH TRIANGLE PARK – MED-EL Medical Electronics, a hearing-technology company with U.S. headquarters in Durham, was recently named “Innovator of…
Gene editing shows promise as tool to fight neuro disorder in babies, UNC study finds Date Published: October 23, 2020 CHAPEL HILL – Babies born with a faulty maternal copy of the UBE3A gene will develop Angelman syndrome, a severe…
With new cash, Durham biopharma startup Emergo targets a big enemy: Flu Date Published: October 22, 2020 RESEARCH TRIANGLE PARK – Who knew there might be a new way to get through to the flu? Consider Moise…
Data sensor startup Tyrata, with links to Duke University, raising new round of cash Date Published: October 21, 2020 DURHAM – Startup Tyrata, which focuses on sensors and data management, continues to attract interest from investors. Looking to raise…
Duke researchers leading $5M project to improve Air Force networks Date Published: October 20, 2020 DURHAM – Researchers at Duke University will work with colleagues across the nation to ensure that future communication protocols used…
IQVIA’s CEO: Life science giant ‘delivering results above our financial targets’ Date Published: October 20, 2020 DURHAM – IQVIA Holdings Inc. (IQV) on Tuesday reported third-quarter profit of $101 million. The Durham, North Carolina-based company said…
Hatteras, one of the Triangle’s most important biotech investors, raises more than $137M Date Published: October 16, 2020 Hatteras Venture Partners, one of the Triangle’s most important biotechnology investors, has raised more $137 million for its newest fund,…
Merck’s expansion in Durham reflects huge legacy of Maurice Hilleman Date Published: October 16, 2020 DURHAM — As you walk through the imposing glass front entrance at Merck’s Maurice R. Hilleman Center for Vaccine Manufacturing…